Binex Sepcim Capsule (Cefixime Trihydrate)

Adult dose

Adults: Administer 50～100mg (potency) of cefixime per dose orally twice daily. For severe infections or an inadequate response, administer 200mg (potency) per dose twice daily. Adjust the dose appropriately according to age and symptoms.

Child dose

Children weighing 30 Kg or more: Administer 50～100mg (potency) of cefixime per dose orally twice daily. For severe infections or an inadequate response, administer 200mg (potency) per dose twice daily. Adjust the dose appropriately according to age and symptoms.

This medication should not be administered to specific patients. Patients who have experienced severe allergic reactions or shock due to this medication, patients with hypersensitivity to cephalosporin antibiotics, patients with lactose intolerance or inherited metabolic disorders should not use this medication. Additionally, patients who have had allergic reactions to this medication or similar antibiotics in the past, patients with hypersensitivity to penicillin antibiotics, patients with allergic dispositions, patients with severely impaired renal function, and patients who have difficulty taking orally or are elderly should use this medication with caution. This medication can rarely cause severe allergic reactions, shock, anaphylaxis symptoms, skin rash, severe diarrhea, membranous colitis, interstitial pneumonia, blood abnormalities, renal function impairment, liver function impairment, central nervous system abnormalities, vitamin deficiency symptoms, etc., so if these symptoms occur, discontinue use immediately and seek appropriate treatment. This medication should be used for the required minimum duration after susceptibility testing to prevent the occurrence of resistant bacteria, and hypersensitivity history should be thoroughly checked before administration. In patients with impaired renal function, dosage adjustment is necessary, and caution should be exercised as seizures may occur. When combined with anticoagulant drugs such as warfarin, this medication may increase the risk of bleeding, so caution is required, and renal function should be closely monitored when used with other nephrotoxic medications. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of this medication's use, and should avoid breastfeeding during the treatment period. Safety in newborns, premature infants, and infants under 6 months has not been established, so caution should be exercised in their use. Elderly patients may exhibit adverse reactions more easily due to decreased physical function, so their condition should be closely monitored during administration, and the risk of bleeding due to vitamin K deficiency should also be noted. This medication may affect the results of some clinical tests, so caution is needed in interpreting test results. Lastly, when used in suspension form, do not store for more than 2 weeks after preparation, and powdered forms should not be kept suspended in milk or juice for long periods.

shock

This medication should be stored in a tightly sealed container to prevent the ingress of air or moisture, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps to maintain the efficacy of the medication.

Appearance

A hard capsule with light orange upper and lower parts containing a crystalline powder that is white to light yellow.

Package unit

30 capsules/bottle